Literature DB >> 21207170

Determining the association between preoperative computed tomography findings and postoperative outcomes after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei.

Terence C Chua1, Abdulaziz Al-Zahrani, Akshat Saxena, Derek Glenn, Winston Liauw, Jing Zhao, David L Morris.   

Abstract

BACKGROUND: This study evaluates the accuracy of computed tomography (CT) scoring of the peritoneal cancer index (PCI) and examines its association with surgical morbidity and outcomes in pseudomyxoma peritonei.
METHODS: Forty-seven patients with pseudomyxoma peritonei had preoperative evaluation of CT scans and were treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy. Their radiological PCI and intraoperative PCI were scored for determination of accuracy and for correlation with morbidity and outcomes.
RESULTS: Accuracy in detecting peritoneal lesions regardless of size ranged from 51% to 85% in the abdominopelvic regions and 21% to 25% in the small intestinal regions. The sensitivity of CT detection of peritoneal implants ranged from 67% to 84% in the abdominopelvic regions and from 56% to 57% in the small intestinal regions. The specificity of CT detection of peritoneal lesions was 100% in all regions. Preoperative CT identification of larger peritoneal lesions in the right upper quadrant (P = 0.016), epigastrium (P = 0.003), left upper quadrant (P = 0.019), proximal jejunum (P = 0.022), distal jejunum (P = 0.022), and proximal ileum (P = 0.022) predicted development of severe complications. Similarly, larger peritoneal lesions in the right upper quadrant (P = 0.039), epigastrium (P = 0.024), right flank (P = 0.005), and right lower quadrant (P = 0.034) were negatively associated with disease-free survival, and the right upper quadrant (P = 0.037) was negatively associated with overall survival.
CONCLUSIONS: Preoperative CT scan depicting extensive upper abdominal and small bowel disease predicts the presence of severe complications after cytoreduction. Extensive disease in the right upper quadrant seems to be associated with a poorer survival outcome.

Entities:  

Mesh:

Year:  2011        PMID: 21207170     DOI: 10.1245/s10434-010-1492-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  11 in total

1.  FDG-PET/ceCT is useful to predict recurrence of Pseudomyxoma peritonei.

Authors:  Julien Dubreuil; Francesco Giammarile; Pascal Rousset; Naoual Bakrin; Guillaume Passot; Sylvie Isaac; Olivier Glehen; Andrea Skanjeti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-02-24       Impact factor: 9.236

Review 2.  Preoperative and surveillance MR imaging of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy.

Authors:  Russell N Low
Journal:  J Gastrointest Oncol       Date:  2016-02

3.  Correlation of Radiologic with Surgical Peritoneal Cancer Index Scores in Patients with Pseudomyxoma Peritonei and Peritoneal Carcinomatosis: How Well Can We Predict Resectability?

Authors:  Kristina Flicek; Awais Ashfaq; C Dan Johnson; Christine Menias; Sanjay Bagaria; Nabil Wasif
Journal:  J Gastrointest Surg       Date:  2015-07-11       Impact factor: 3.452

4.  Impact of a modified peritoneal cancer index using FDG-PET/CT (PET-PCI) in predicting tumor grade and progression-free survival in patients with pseudomyxoma peritonei.

Authors:  Masatoshi Hotta; Ryogo Minamimoto; Yoshimasa Gohda; Toru Igari; Hideaki Yano
Journal:  Eur Radiol       Date:  2019-03-14       Impact factor: 5.315

5.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: outcomes from a single tertiary institution.

Authors:  Parissa Tabrizian; Brian Shrager; Ghalib Jibara; Ming-Jim Yang; Anya Romanoff; Spiros Hiotis; Umut Sarpel; Daniel M Labow
Journal:  J Gastrointest Surg       Date:  2014-02-28       Impact factor: 3.452

6.  A Simplified Preoperative Assessment Predicts Complete Cytoreduction and Outcomes in Patients with Low-Grade Mucinous Adenocarcinoma of the Appendix.

Authors:  Sean P Dineen; Richard E Royal; Marybeth S Hughes; Tara Sagebiel; Priya Bhosale; Michael Overman; Aurelio Matamoros; Paul F Mansfield; Keith F Fournier
Journal:  Ann Surg Oncol       Date:  2015-02-20       Impact factor: 5.344

7.  Accuracy of whole-body diffusion-weighted MRI (WB-DWI/MRI) in diagnosis, staging and follow-up of gastric cancer, in comparison to CT: a pilot study.

Authors:  Sofie De Vuysere; Vincent Vandecaveye; Yves De Bruecker; Saskia Carton; Koen Vermeiren; Tim Tollens; Frederik De Keyzer; Raphaëla Carmen Dresen
Journal:  BMC Med Imaging       Date:  2021-02-05       Impact factor: 1.930

Review 8.  Secreted mucins in pseudomyxoma peritonei: pathophysiological significance and potential therapeutic prospects.

Authors:  Afshin Amini; Samar Masoumi-Moghaddam; Anahid Ehteda; David Lawson Morris
Journal:  Orphanet J Rare Dis       Date:  2014-05-05       Impact factor: 4.123

9.  Value of preoperative ultrasound in evaluating the peritoneal cancer index of pseudomyxoma peritonei.

Authors:  Lei Liang; Wenhai Wang; Nan Zhou; Jun Guo; Yiyan Lu; Hongbin Xu; Shutian Zhang
Journal:  World J Surg Oncol       Date:  2019-11-12       Impact factor: 2.754

10.  CRS and HIPEC in patients with peritoneal metastasis secondary to colorectal cancer: The small-bowel PCI score as a predictor of survival.

Authors:  John Spiliotis; Vasileios Kalles; Ioannis Kyriazanos; Alexios Terra; Anastasia Prodromidou; Apostolos Raptis; Nikolaos Kopanakis; Athina Christopoulou
Journal:  Pleura Peritoneum       Date:  2019-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.